secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2024-11-13T23:59:59+00:00
Accession:  0001213900-24-097495
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq panel grants Citius Pharma extension to regain bid price compliance by Dec 3, 2024
--------------------------------------------------------------------------------

- Company received bid price deficiency notice on Sep 12, 2023, extended to Sep 9, 2024.
- After failing to regain compliance, hearing requested and held on Oct 29, 2024.
- Panel decision on Nov 6, 2024 grants continued listing subject to compliance deadline Dec 3, 2024.
- Company must provide prompt notification of any significant events affecting compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024097495/0001213900-24-097495-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024097495/ea0221050-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-097495

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer